Trade Mark Journal No.2026/006 6 February 2026

UK00004326200 19 January 2026 (41)

RHEUM.AI

Class 41: Medical and technical education and training services in the field of autoimmune diseases.

AbbVie Biotechnology Ltd

Representative: Carpmaels & Ransford LLP